Cargando…
Metastatic medullary thyroid carcinoma: A case report
Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S),...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214365/ https://www.ncbi.nlm.nih.gov/pubmed/22091276 |
_version_ | 1782216246851272704 |
---|---|
author | Niafar, Mitra Dabiri, Shahram Bozorgi, Farshid Niafar, Farid Gholami, Nasrin |
author_facet | Niafar, Mitra Dabiri, Shahram Bozorgi, Farshid Niafar, Farid Gholami, Nasrin |
author_sort | Niafar, Mitra |
collection | PubMed |
description | Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S), are used for detecting recurrences following total thyroidectomy. However, metastatic disease frequently escapes detection by the above modalities, even when its presence is suggested by persistently elevated serum calcitonin levels. In this paper, we report a case of medullary thyroid carcinoma in a 40 year-old woman who had whole body octreotide scintigraphy to evaluate and detect the origin of calcitonin and CEA secretion. |
format | Online Article Text |
id | pubmed-3214365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32143652011-11-16 Metastatic medullary thyroid carcinoma: A case report Niafar, Mitra Dabiri, Shahram Bozorgi, Farshid Niafar, Farid Gholami, Nasrin J Res Med Sci Case Report Medullary thyroid carcinoma accounts for 4% of thyroid carcinoma and originates from parafollicular cells, secreting calcitonin and carcinoembryonic antigen (CEA). Conventional radiographic modalities such as Computerized Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasonography (U/S), are used for detecting recurrences following total thyroidectomy. However, metastatic disease frequently escapes detection by the above modalities, even when its presence is suggested by persistently elevated serum calcitonin levels. In this paper, we report a case of medullary thyroid carcinoma in a 40 year-old woman who had whole body octreotide scintigraphy to evaluate and detect the origin of calcitonin and CEA secretion. Medknow Publications Pvt Ltd 2011-04 /pmc/articles/PMC3214365/ /pubmed/22091276 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Niafar, Mitra Dabiri, Shahram Bozorgi, Farshid Niafar, Farid Gholami, Nasrin Metastatic medullary thyroid carcinoma: A case report |
title | Metastatic medullary thyroid carcinoma: A case report |
title_full | Metastatic medullary thyroid carcinoma: A case report |
title_fullStr | Metastatic medullary thyroid carcinoma: A case report |
title_full_unstemmed | Metastatic medullary thyroid carcinoma: A case report |
title_short | Metastatic medullary thyroid carcinoma: A case report |
title_sort | metastatic medullary thyroid carcinoma: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214365/ https://www.ncbi.nlm.nih.gov/pubmed/22091276 |
work_keys_str_mv | AT niafarmitra metastaticmedullarythyroidcarcinomaacasereport AT dabirishahram metastaticmedullarythyroidcarcinomaacasereport AT bozorgifarshid metastaticmedullarythyroidcarcinomaacasereport AT niafarfarid metastaticmedullarythyroidcarcinomaacasereport AT gholaminasrin metastaticmedullarythyroidcarcinomaacasereport |